Sumatriptan Succinate Injection Articles
FDA accepts Spectrum's ANDA for cancer drug
1 August 2005
US ANDA filings "buy time for branded drugs"
24 January 2005
FDA accepts Spectrum's sumatriptan ANDA
17 January 2005
UK FIRMS BOOSTED BY YEAR-END US APPROVALS
4 January 1993
Showing 1-4 of 4 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
